Omblastys

FDA Action Alert: Spectrum, ImmunoGen, Scynexis and Y-mAbs
BioSpace
Mon, 11/21/22 - 10:06 am
FDA
Spectrum Pharmaceuticals
poziotinib
Immunogen
mirevtuximab soravtansine
Scynexis
Brexafemme
Y-mAbs
Omblastys